NYSEMKT: MTNB
Matinas Biopharma Holdings Inc Stock Ownership - Who owns Matinas Biopharma Holdings?

Insider buying vs selling

Have Matinas Biopharma Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MTNB insiders and whales buy or sell their stock.

MTNB Shareholders

What type of owners hold Matinas Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adam K. Stern179.09%9,110,069$19.59MInsider
Herbert J. Conrad169.15%8,604,510$18.50MInsider
Roelof Rongen69.58%3,539,416$7.61MInsider
Jennifer Lorenzo41.02%2,086,576$4.49MInsider
Raphael J. Mannino37.74%1,919,715$4.13MInsider
Abdel A. Fawzy33.82%1,720,186$3.70MInsider
Jerome D. Jabbour16.51%840,011$1.81MInsider
James S. Scibetta12.78%649,958$1.40MInsider
Stefano Ferrari10.92%555,547$1.19MInsider
Patrick G. Lepore7.86%400,000$860.00kInsider

1 of 3

MTNB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTNB0.91%99.09%
XTLB0.03%12.85%
BOLT4.27%95.73%Net Buying
INAB3.61%96.39%Net Buying
PCSA0.74%8.06%Net Buying

Matinas Biopharma Holdings Stock Ownership FAQ

Who owns Matinas Biopharma Holdings?

Matinas Biopharma Holdings (NYSEMKT: MTNB) is owned by 5.43% institutional shareholders, 591.27% Matinas Biopharma Holdings insiders, and 0.00% retail investors. Adam K. Stern is the largest individual Matinas Biopharma Holdings shareholder, owning 9.11M shares representing 179.09% of the company. Adam K. Stern's Matinas Biopharma Holdings shares are currently valued at $19.13M.

If you're new to stock investing, here's how to buy Matinas Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.